Cyclooxygenase-2 deficiency attenuates lipopolysaccharide-induced inflammation, apoptosis, and acute lung injury in adult mice

Abstract

Many lung diseases are caused by an excessive inflammatory response, and inflammatory lung diseases are often modeled using lipopolysaccharide (LPS) in mice. Cyclooxygenase-2 (COX-2) encoded by the Ptgs2 gene is induced in response to inflammatory stimuli including lipopolysaccharide (LPS). The objective of this study was to test the hypothesis that mice deficient in COX-2 (Ptgs2-/-) will be protected from LPS-induced lung injury. Wild type (WT, CD1 mice) and Ptgs2-/- mice (on a CD1 background) were treated with LPS or vehicle for 24 hours. LPS-treatment resulted in histological evidence of lung injury, which was attenuated in the Ptgs2-/- mice. LPS-treatment increased the mRNA levels for tumor necrosis factor (TNF)-α, interleukin (IL)-10, and monocyte chemoattractant protein (MCP)-1 in the lungs of WT mice, and the LPS-induced increases in these levels were attenuated in the Ptgs2-/- mice. The protein levels of active caspase-3 and caspase-9 were lower in the LPS-treated lungs of Ptgs2-/- mice than in LPS-treated WT mice, as were the number of TUNEL positive cells in lung sections. LPS exposure resulted in greater lung wet-to-dry weight ratio (W/D) in WT mice, suggestive of pulmonary edema; while in LPS-treated Ptgs2-/- mice the W/D was not different from controls and less than in LPS-treated WT mice. These results demonstrate that COX-2 is involved in the inflammatory response to LPS, and suggest that COX-2 not only acts as a downstream participant in the inflammatory response, but also acts as a regulator of the inflammatory response likely through a feed-forward mechanism following LPS stimulation.

6'-O-galloylpaeoniflorin alleviates inflammation and oxidative stress in pediatric pneumonia through activating Nrf2 activation

“…[13][14][15] LPS activates a large number of inflammatory cells and induces pneumonia through a variety of signaling pathways. [16][17][18] In this study, we successfully constructed a pneumonia model using LPS, and confirmed the effects of GPF on this model.…”

Integrated metabolomics, network pharmacology and biological verification to reveal the mechanisms of Nauclea officinalis treatment of LPS-induced acute lung injury

“…PTGS2, also known as cyclooxygenase, can catalyze AA to generate PGs, which are mainly involved in inflammation, cell proliferation and apoptosis. In addition, PTGS1 can regulate angiogenesis in endothelial cells [ 51 ]. PLA2G1B is a phospholipase A2 that catalyzes membrane glycerophospholipids to release AA and Lys phospholipids, which are involved in cell contraction and proliferation.…”

Yangyinqingfei decoction attenuates PM2.5-induced lung injury by enhancing arachidonic acid metabolism

“…These three pathways of AA were closely related to lung injury. Mice deficient in COX-2 could attenuate LPS-induced inflammatory response and the resultant acute lung injury by regulation of LPS-induced levels of cytokines/chemokines ( Nelin et al, 2022 ). 12/15-LOX was shown to be involved in the regulation of eicosanoid production in the respiratory system using knockout mice model.…”